All manuscripts and correspondence can be submitted by e-mail to the address pneumon@hts.org.gr. All submissions should include a Cover Letter and a single Manuscript file (including Body of Manuscript, References, Tables, Figure Legends, and Figures). Figures may be submitted also as separate files. All text should be double-spaced using 12-point typeface (Arial or Times New Roman) and should be prepared in a word processing format (Microsoft Word preferred; an acceptable alternative would be PDF format). For the suggested length of publications please refer to Table 1 at the end of this document.
All manuscripts should be accompanied by a cover letter, signed by the corresponding author, clearly stating the following:
1. Neither the article nor any part of its essential substance has been or will be published or submitted elsewhere; if papers closely related to the submitted manuscript have been published or submitted for publication elsewhere, the authors should provide details.
2. The clinical relevance of the work described and what it adds to the current literature.
3. Potential significant conflicts of interest.
4. The manuscript has been prepared according to the instructions for authors of PNEUMON and all authors have read and approved the text of the article.
5. If accepted for publication, the copyright will be transferred to PNEUMON Journal.
Failure to provide a cover letter addressing each of the points above will result in the paper being returned to the author. The cover letter must be presented as a separate submission item.
1. The title of the manuscript (no more than 10 words). If it is necessary the title can include a sub-title
2. The full name, institutions, city and country for all co-authors
3. The full name, postal address, e-mail, telephone, and fax numbers of the corresponding author.
4. Conflicts of interest of all authors.
5. Potential funding or grant support of the work described.
6. A running (short) title.
7. The total number of words of the manuscript and the abstract.
Abstract
A structured abstract should be provided of up to 250 words. It should consist of four paragraphs, labeled Background, Methods, Results, and Conclusions. They should briefly describe, respectively, the problem being addressed in the study, how the study was performed, the most important results, and what the authors conclude from the results. Abbreviations should be avoided and, if used, they should be explained the first time mentioned.
Keywords
Up to 5 keywords that reflect the content of the manuscript should be provided. Authors should consult the Medical Subject Headings (MeSH) website (available at http://www.nlm.nih.gov/mesh/meshhome.html; accessed on November 9, 2008).
Abbreviations
Please provide an alphabetical list of all abbreviations used in the manuscript on a separate page. For clarity reasons, please use abbreviations sparingly. When abbreviations are used, they should be explained the first time they are mentioned in the text.
Body of Manuscript
The paper should include the following sections:
Introduction
The rationale for the study should be summarized and relevant background material outlined. The Introduction should not contain findings, methods used or conclusions.
Methods
Methods should be described in adequate detail to assure the reader as to how the results were obtained. In manuscripts reporting human research, the authors should report approval by the Review Board or Ethics Committee and that written informed consent was obtained from patients. The location (city, state, country) of a manufacturer listed in the text should be provided. Units should conform to SI conventions. Generic names of drugs should be used instead of trade names. Statistical methods should be meticulously described and referenced.
Results
Results should be presented in a rational order in the text, tables and figures. The authors should avoid repetitive presentation of the same data in different forms, especially between the text and tables and figures. The Results should not include material appropriate to the Discussion.
Discussion
The discussion should start by presenting the new and most interesting data of the work in relation to any hypotheses made in the Introduction. Any unexpected or contradictory results should be explained or defended. For example, evaluation of methodology and the associations of new information to the existing knowledge in the topic should be discussed. Speculation should be kept to a minimum. The results must not be simply reiterated. New results should not appear in the Discussion. No specific reference to figures and tables should be included in the Discussion.
Acknowledgements
Acknowledge the persons who provided a true contribution and who endorse the data and conclusions. Acknowledge any funding sources.
References
Only published works may be cited as references. Manuscripts accepted but not yet published may be cited designating the accepting journal, followed by the term (in press), and copies of the in-press articles should be provided for reviewer inspection. References should be cited in the manuscript with superscript numerals in the order in which they appear in the text. The full list of references should be provided in numerical order on a separate page at the end of the text. References should include, in order, the following: authors, title, source, year of publication, volume, and inclusive page numbers. All authors should be listed if they are six or fewer; when they are seven or more, list the first three followed by "et al." Please abbreviate journal names as in Index Medicus (available at http://www.nlm.nih.gov/tsd/serials/lji.html; accessed on November 9, 2008).
The following are sample references:
- Standard journal article: Bouros D, Antoniou KM, Light RW. Intrapleural streptokinase for pleural infection. BMJ 2006; 332:133-4.
- Books and other monographs: Siafakas NM, Anthonisen N, Georgopoulos D. Acute exacerbations of COPD. Marcel Dekker, New York, 2004.
- Chapter in a book: Kyriakou D, Alexandrakis M, Bouros D. Pleural effusions in blood diseases. In: Bouros D. (editor). Pleural Disease. Marcel Dekker, New York, 2004, pp. 621-638.
Numbered references to personal communications, unpublished data, or manuscripts either "in preparation" or "submitted for publication" are unacceptable. If essential, such material can be incorporated at the appropriate place in the text.
Tables
Double-space tables (including any footnotes) should be presented on separate pages, providing a title for each. Any abbreviations used in a Table should be defined in the Table's footnote.
Figures
Figures may be inserted in the text file or in a separate file (accepted formats are JPEG, TIFF and EPS). Legends for all figures should be included in the file with the text, on a separate page after the Tables, and should not appear on the actual figures. If photographs of patients are used, they should either not be identifiable or the photographs should be accompanied by written permission to use them.
Permission
The manuscript must be accompanied by copies of permission to reproduce previously published material (figures or tables); to use illustrations of, or report sensitive personal information about, identifiable persons; and to name persons in the Acknowledgments section.
PNEUMON is the official scientific journal of the Hellenic Thoracic Society and the Hellenic Bronchologic Society ISSN: 1791-4914 (ONLINE)
ISSN: 1105-848X (PRINT)
Journal metadata